1. Search Result
Search Result
Results for "

acetylneuraminic acid

" in MedChemExpress (MCE) Product Catalog:

20

Inhibitors & Agonists

5

Biochemical Assay Reagents

3

Natural
Products

2

Recombinant Proteins

7

Isotope-Labeled Compounds

1

Click Chemistry

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-I0400
    N-Acetylneuraminic acid
    3 Publications Verification

    NANA; Lactaminic acid

    Tyrosinase Ras Influenza Virus Endogenous Metabolite Cardiovascular Disease Inflammation/Immunology Cancer
    N-Acetylneuraminic acid (NANA; Lactaminic acid), a nonphenolic structure, is the predominant form of sialic from Collocalia esculenta. N-Acetylneuraminic acid plays a biological role in myocardial injury, melanoma and viral or bacterial infection. N-Acetylneuraminic acid inhibits melanogenesis by reducing tyrosinase activity and triggers myocardial injury in vitro and in vivo by activation of the Rho/Rho-associated signaling pathway through binding to RhoA and Cdc42. N-Acetylneuraminic acid may prevent high fat diet (HFD)-induced inflammation and oxidative stress, thereby prevents hyperlipidemia-associated inflammation and oxidative stress. N-Acetylneuraminic acid is promising for research in the field of melanoma, coronary artery, obesity-related diseases and hyperlipidemia .
    N-Acetylneuraminic acid
  • HY-151852

    Endogenous Metabolite Cardiovascular Disease
    9AzNue5Ac, 9-azido-9-deoxy-N-acetylneuraminic acid, is a click chemistry reagent and a Neu5Ac analogue with the substitution of 9-hydroxyl group with an azide. 9AzNue5Ac could be metabolized and incorporated into sialoglycans in living cells and mice. Click chemistry has great potential for use in binding between nucleic acids, lipids, proteins, and other molecules, and has been used in many research fields because of its beneficial characteristics, including high yield, high specificity, and simplicity . It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
    9AzNue5Ac
  • HY-I0400R

    Tyrosinase Ras Influenza Virus Endogenous Metabolite Cardiovascular Disease Inflammation/Immunology Cancer
    N-Acetylneuraminic acid (Standard) is the analytical standard of N-Acetylneuraminic acid. This product is intended for research and analytical applications. N-Acetylneuraminic acid (NANA; Lactaminic acid), a nonphenolic structure, is the predominant form of sialic from Collocalia esculenta. N-Acetylneuraminic acid plays a biological role in myocardial injury, melanoma and viral or bacterial infection. N-Acetylneuraminic acid inhibits melanogenesis by reducing tyrosinase activity and triggers myocardial injury in vitro and in vivo by activation of the Rho/Rho-associated signaling pathway through binding to RhoA and Cdc42. N-Acetylneuraminic acid may prevent high fat diet (HFD)-induced inflammation and oxidative stress, thereby prevents hyperlipidemia-associated inflammation and oxidative stress. N-Acetylneuraminic acid is promising for research in the field of melanoma, coronary artery, obesity-related diseases and hyperlipidemia .
    N-Acetylneuraminic acid (Standard)
  • HY-I0400S

    NANA-13C; Lactaminic acid-13C

    Isotope-Labeled Compounds Endogenous Metabolite Influenza Virus Cardiovascular Disease
    N-Acetylneuraminic acid- 13C is the 13C labeled N-Acetylneuraminic acid.
    N-Acetylneuraminic acid-13C
  • HY-W553914

    Biochemical Assay Reagents Others
    N-Acetylneuraminic acid 2,4,7,8,9-pentaacetate is a biochemical assay reagent.
    N-Acetylneuraminic acid 2,4,7,8,9-pentaacetate
  • HY-I0400S1

    NANA-13C-1; Lactaminic acid-13C-1

    Isotope-Labeled Compounds Endogenous Metabolite Influenza Virus Cardiovascular Disease
    N-Acetylneuraminic acid- 13C-1 is the 13C labeled N-Acetylneuraminic acid.
    N-Acetylneuraminic acid-13C-1
  • HY-I0400S2

    NANA-13C-2; Lactaminic acid-13C-2

    Isotope-Labeled Compounds Endogenous Metabolite Influenza Virus Cardiovascular Disease
    N-Acetylneuraminic acid- 13C-2 is the 13C labeled N-Acetylneuraminic acid.
    N-Acetylneuraminic acid-13C-2
  • HY-I0400S3

    NANA-13C-3; Lactaminic acid-13C-3

    Isotope-Labeled Compounds Endogenous Metabolite Influenza Virus Cardiovascular Disease
    N-Acetylneuraminic acid- 13C-3 is the 13C labeled N-Acetylneuraminic acid.
    N-Acetylneuraminic acid-13C-3
  • HY-137878

    PNP-α-NeuNAc

    Endogenous Metabolite Others
    2-O-(p-Nitrophenyl)-α-D-N-acetylneuraminic acid (PNP-α-NeuNAc) acts as a sialyl donor in the process of enzyme-catalyzed trans-sialylation.
    2-O-(p-Nitrophenyl)-α-D-N-acetylneuraminic acid
  • HY-W145628

    Biochemical Assay Reagents Others
    4,7,8,9-Tetra-O-acetyl-N-acetylneuraminic acid methyl ester is a class of biochemical reagents used in glycobiology research. Glycobiology studies the structure, synthesis, biology, and evolution of sugars. It involves carbohydrate chemistry, enzymology of glycan formation and degradation, protein-glycan recognition, and the role of glycans in biological systems. This field is closely related to basic research, biomedicine, and biotechnology .
    4,7,8,9-Tetra-O-acetyl-N-acetylneuraminic acid methyl ester
  • HY-105284R

    Beta-lactamase Bacterial Antibiotic Infection
    N-Acetylneuraminic acid (Standard) is the analytical standard of N-Acetylneuraminic acid. This product is intended for research and analytical applications. N-Acetylneuraminic acid (NANA; Lactaminic acid), a nonphenolic structure, is the predominant form of sialic from Collocalia esculenta. N-Acetylneuraminic acid plays a biological role in myocardial injury, melanoma and viral or bacterial infection. N-Acetylneuraminic acid inhibits melanogenesis by reducing tyrosinase activity and triggers myocardial injury in vitro and in vivo by activation of the Rho/Rho-associated signaling pathway through binding to RhoA and Cdc42. N-Acetylneuraminic acid may prevent high fat diet (HFD)-induced inflammation and oxidative stress, thereby prevents hyperlipidemia-associated inflammation and oxidative stress. N-Acetylneuraminic acid is promising for research in the field of melanoma, coronary artery, obesity-related diseases and hyperlipidemia .
    Sulopenem (Standard)
  • HY-P2988B

    Endogenous Metabolite Infection
    Neuraminidase, arthrobacter ureafaciens is an exosialidase which cleaves α-ketosidic linkage between the sialic (N-acetylneuraminic) acid and an adjacent sugar residue. Neuraminidase can facilitate virus release from infected cells .
    Neuraminidase, arthrobacter ureafaciens
  • HY-128850S1

    N-Acetylmannosamine-13C; ManNAc-13C

    Bacterial Neurological Disease
    N-Acetyl-D-mannosamine- 13C is the 13C labeled N-Acetyl-D-mannosamine. N-Acetyl-D-mannosamine (ManNAc) is an essential precursor of N-acetylneuraminic acid (NeuAc), the specific monomer of bacterial capsular polysialic acid (PA)[1][2]
    N-Acetyl-D-mannosamine-13C
  • HY-128850S5

    N-Acetylmannosamine-15N; ManNAc-15N

    Isotope-Labeled Compounds Bacterial Neurological Disease
    N-Acetyl-D-mannosamine- 15N is the 15N labeled N-Acetyl-D-mannosamine. N-Acetyl-D-mannosamine (ManNAc) is an essential precursor of N-acetylneuraminic acid (NeuAc), the specific monomer of bacterial capsular polysialic acid (PA)[1][2]
    N-Acetyl-D-mannosamine-15N
  • HY-P2988

    Exo-α-sialidase

    Endogenous Metabolite Infection
    Neuraminidase, Microorganism (Exo-α-sialidase) is an exosialidase, is often used in biochemical studies. Neuraminidase cleaves α-ketosidic linkage between the sialic (N-acetylneuraminic) acid and an adjacent sugar residue. Neuraminidase, derived from mucosal pathogens, is a virulence factor that modifies the host's response to infection .
    Neuraminidase, Microorganism
  • HY-P2977

    Sialic acid aldolase (CgNal)

    Endogenous Metabolite Others
    N-Acetylneuraminate lyase (CgNal) (Sialic acid aldolase (CgNal)) is a class I aldolase, is often used in biochemical studies. N-Acetylneuraminate lyase (CgNal) catalyzes the reversible condensation of pyruvate with N-acetyl-d-mannosamine (ManNAc) to yield the sialic acid N-acetylneuraminic acid (Neu5Ac) .
    N-Acetylneuraminate lyase (CgNal)
  • HY-128850S2

    N-Acetylmannosamine-13C-1; ManNAc-13C-1

    Isotope-Labeled Compounds Bacterial Neurological Disease
    N-Acetyl-D-mannosamine- 13C-1 is the 13C labeled N-Acetyl-D-mannosamine. N-Acetyl-D-mannosamine (ManNAc) is an essential precursor of N-acetylneuraminic acid (NeuAc), the specific monomer of bacterial capsular polysialic acid (PA)[1][2]
    N-Acetyl-D-mannosamine-13C-1
  • HY-125798

    Neu5Ac2en; DANA

    Influenza Virus Infection
    N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid (Neu5Ac2en) is a potent neuraminidase (sialidase) inhibitor. N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid shows inhibitory activities against human neuraminidase enzymes with IC50s of 143, 43, 61, and 74 μM for NEU1, NEU2, NEU3, and NEU4, respectively. Anti-influenza virus activity .
    2,3-Dehydro-2-deoxy-N-acetylneuraminic acid
  • HY-E70150

    EC:2.4.3.3; Alpha-N-Acetylgalactosaminide alpha-2,6-sialyltransferase 1

    Sialyltransferase Cancer
    ST6 Sialyltransferase 1 (EC:2.4.3.3, ST6GALNAC1, SIAT7A, Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1)? transfers a sialic acid, N-acetylneuraminic acid (NeuAc), in an alpha-2,6 linkage to O-linked GalNAc residues. ST6 Sialyltransferase 1 plays an important role in cancer .
    ST6 Sialyltransferase 1
  • HY-161943

    Influenza Virus Neurological Disease
    NEU3-IN-2 (compound 963) is a NEU3 inhibitor (Ki: 0.12 μM; IC50: 0.31 μM) based on the 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) scaffold and is a C9 biphenylcarbamate derivative. NEU is a human neuraminidase with 4 isozymes; NEU3-IN-2 is an important tool for studying the function of NEU3 isozymes; its amide and triazole linker analogs are selective for NEU1 and NEU4 isozymes, respectively .
    NEU3-IN-1

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: